A Comparison of Duloxetine Hydrochloride, Marketed Comparator, and Placebo in the Treatment of Generalized Anxiety Disorder

NCT00122837 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

560

Enrollment

INDUSTRY

Sponsor class

Conditions

Anxiety Disorder

Interventions

DRUG: Duloxetine
DRUG: venlafaxine
DRUG: placebo

Sponsor

Eli Lilly and Company

Collaborators

[object Object]